Martin Bakker has served as Chief Business Officer at InnoCore Pharmaceuticals since 2015. With over two decades of experience in business development and marketing within the pharmaceutical industry, he has held leadership roles at companies including OctoPlus, Dr. Reddy’s, Northern Lipids (now Evonik), and PRA Health Sciences (now ICON). Martin also provides consultancy services through Bakker Life Science and holds a Ph.D. in Chemistry from Delft University of Technology.